Te whakamātau poka rekereke — he whakamātau i te whakarau pūngao o te pēpi hou Heel prick test — newborn metabolic screening
About the heel prick test
The heel prick test is when a blood sample is taken from your baby's heel. Four small blood drops are collected on a special card. The blood is then:
- sent to a screening lab
- tested for certain disorders that are difficult to identify without a blood test.
Screening can find these disorders before symptoms appear. This means you can get early treatment for your pēpi. If your baby's screen shows an increased risk of a disorder, they will need a diagnostic test to confirm if they have a disorder.
Before the sample is taken
Your lead maternity carer (LMC) or midwife will talk to you about the screening test and give you the opportunity to ask questions. They will also give you a brochure that has information about the Newborn Metabolic Screening Programme. The information given to you will include:
- discussion about the screening test
- storage of the card
- possible future uses and the option of return
- results
- follow-up processes.
Once your LMC or hospital midwife has your consent, they or a trained blood taker (phlebotomist) will take the sample. This can be done in the hospital, or at home.
How the heel prick is done — taking the blood sample
The blood sample is taken when your pēpi is 24 hours old, or as soon as possible after this, but it should be taken before they are 72 hours old.
A blood sample is taken from your baby's heel using a device called a lancet. This makes a small puncture on the side of their heel. You can prepare your pēpi for the sample to be taken by putting booties on them, or wrapping their feet well. This makes sure that your baby's heel is warm, and it is easier and quicker to take the blood sample.
Having a heel prick might cause your baby some discomfort. You can reduce your baby’s discomfort by feeding or cuddling your baby while the blood sample is being taken. Your LMC or midwife can talk to you about other ways of keeping your baby comfortable while the blood sample is taken.
A blood spot card collects the sample. After the test, you can apply gentle pressure to the heel using cotton wool to stop the bleeding. Your midwife will send the card to the lab for testing.
Why the screen is done at 24 hours
When a baby with one of the screened for disorders is in the womb, the placenta clears away any abnormal biochemical levels as the baby’s system produces them.
When the baby is born, the baby’s own system takes over and if the baby has a disorder, the biochemicals can accumulate to toxic levels or cause other problems.
The baby’s own system should be working properly at 24 hours of age, so this is the best time to do the screen — when your baby’s system is working independently, and before your baby gets sick.
Screen results
If the screen results are normal you will hear from your LMC or midwife within 10 days of screening.
Repeat samples
Your pēpi may need another heel prick or blood spot collection if:
- there was too much or not enough blood in the sample
- the blood sample was contaminated, for example with baby powder or lotion
- it took too long to reach the lab, which can make the result inaccurate
- results are borderline (slightly abnormal).
If this happens your LMC or midwife will contact you and ask to take another sample. It is important that the new sample is taken as soon as possible so that your baby completes screening.
If the screen result is abnormal
If the screen result is abnormal and suggests a probable disorder, the lab will call your LMC or midwife as soon as possible. Your midwife will explain the result and next steps.
Your midwife will arrange for an assessment and diagnostic testing with a paediatrician. The paediatrician will confirm whether they have a disorder.
Not all babies with an abnormal screen result will be found to have a screened disorder. Other possible reasons for an abnormal result can include being born premature.
If your pēpi has a disorder
If diagnostic testing confirms your pēpi has a disorder, the paediatrician will:
- provide any urgent care your baby needs
- talk to you about what this means, including any ongoing treatment and management of the disorder your baby may need.
Treatment, either diet or medication, is best if started early, before the baby becomes sick, and can help your baby stay well and prevent severe disability or even death.
The blood spot card after the screen
After screening, the blood spot card will be stored forever in a secure locked area. Only authorised staff from the screening programme can access stored blood spots.
If you have requested it be returned, the lab will send it back to you.
Requesting the return of the screening sample
You can ask for your baby's blood spot card back after screening is complete or at any time in the future.
If you would like to request your baby's blood spot card, please download and complete the form below and send it to the laboratory. You will be sent the top part of your baby’s blood spot card with the specimen collection paper holding the blood sample.
- Return of newborn metabolic screening samples to family — request form [DOC, 98 KB]internal link
- Return of newborn metabolic screening samples to family — request form [PDF, 149 KB]internal link
Immediate family members can also request the blood spot cards of a person that has died by completing this form.
DNA
Testing for some screened disorders involves looking for a common change (variant) in a section of DNA (gene). These variants are known to be associated with the disorder.
The testing is limited to only a small number of genes known to be linked to specific screened disorders.
No other genetic testing is done on samples unless first discussed and authorised by the parents, guardians, individual or through legal avenues, for example a court order.
Safeguards for the newborn metabolic screening programme
The laboratory which performs the screening for the programme must be International Accreditation New Zealand (IANZ) accredited against the international standard ISO 15189. This is the highest accreditation programme available. Accreditation by IANZ ensures the laboratory that carries out these tests is technically competent, has appropriate processes and is using up-to-date technology.
More information is available from the IANZ website.
International Accreditation New Zealand (IANZ) (external link)
Related websites
Newborn Screening Info external link
Contains fact sheets about disorders commonly screened for by newborn screening. Because it is an overseas site, not all information will be relevant to Aotearoa. For example, some disorders mentioned are not currently screened for in Aotearoa.
New Zealand Organisation for Rare Disorders external link
Rare Disorders NZ provides New Zealand's central starting point for information about rare disorders. They can refer you to support groups for specific disorders.
Cystic Fibrosis NZ external link
The Cystic Fibrosis NZ website provides information about cystic fibrosis. You can also find out about community support leads, and support groups.